Construction of Cisplatin-18-Crown-6 Complexes Through Supramolecular Chemistry to Improve Solubility, Stability, and Antitumor Activity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413411 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yue Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Jinan University, Guangzhou 511436, China. Hauptthemen laut MEDLINE: Crown Ethers, Antineoplastic Agents, Solubility, Cisplatin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Hainan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Cisplatin (DDP), a platinum-chelated compound renowned for its antitumor activity, is often utilized in cancer therapy. However, its real-world clinical efficacy is compromised by poor solubility and low stability, which impedes wider clinical application. Our study aimed to address these limitations of DDP through host–guest supramolecular chemistry approaches. We explored the potential of 18-crown-6 as the host molecule to solubilize and stabilize DDP, the guest molecule. Utilizing techniques such as UV–visible spectroscopy, Fourier-transform infrared spectroscopy, Raman spectroscopy, and molecular docking, we conducted a comprehensive analysis on the physical state and inclusion mode of the DDP@18-crown-6 complex. Phase solubility studies and Job’s plot confirmed that the DDP@18-crown-6 complex significantly enhanced the aqueous solubility of DDP, with an optimal 1:1 binding ratio. Stability analyses revealed that this complex markedly improved the stability of DDP in pure water. Meanwhile, the stabilization effects of DDP@18-crown-6 were remarkably elevated when combined with 0.9% sodium chloride. In vitro antitumor assays in A549 cell lines demonstrated that the DDP@18-crown-6 complex outperformed raw DDP in cytotoxicity, showing a significantly lower IC50 value. This research offered a promising strategy for DDP solubilization and stabilization, facilitating its anticancer therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, College of Pharmacy, Jinan University, Guangzhou 511436, China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Pharmacy, Jinan Univer…
- Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
ORCID-Profile: Ling Guo, Zhengwei Huang
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Hainan Provincial Natural Science Foundation of China
Zitieren
APA
Gao, Y., Huang, Y., Ren, C., Xiong, S., Guo, X., Zhao, Z., Guo, L., & Huang, Z. (2024). Construction of Cisplatin-18-Crown-6 Complexes Through Supramolecular Chemistry to Improve Solubility, Stability, and Antitumor Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413411
Vancouver
Gao Y, Huang Y, Ren C, Xiong S, Guo X, Zhao Z, et al. Construction of Cisplatin-18-Crown-6 Complexes Through Supramolecular Chemistry to Improve Solubility, Stability, and Antitumor Activity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413411
BibTeX
@article{Gao2024,
author = {Gao, Yue and Huang, Yeqi and Ren, Chuanyu and Xiong, Si and Guo, Xia and Zhao, Ziyu and Guo, Ling and Huang, Zhengwei},
title = {Construction of Cisplatin-18-Crown-6 Complexes Through Supramolecular Chemistry to Improve Solubility, Stability, and Antitumor Activity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413411}
}
EUVIMED